|
|
||||||||
J Thorac Cardiovasc Surg 2009;137:459-464
© 2009 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
a Department of Surgery, The University of Vermont College of Medicine, Burlington, Vt
b Department of Pharmacology, The University of Vermont College of Medicine, Burlington, Vt
Received for publication June 10, 2008; revisions received July 25, 2008; accepted for publication August 13, 2008. * Address for reprints: Joseph D. Schmoker, MD, Division of Cardiothoracic Surgery, Fletcher Allen Health Care, Fletcher 454, 111 Colchester Ave, Burlington, VT 05401. (Email: joseph.schmoker{at}vtmednet.org).
| Abstract |
|---|
|
|
|---|
Methods: Four mature swine underwent hypothermic circulatory arrest for 60 minutes, and 7 mature swine underwent cold cerebral perfusion for 60 minutes to simulate antegrade selective perfusion. All were rewarmed and weaned from cardiopulmonary bypass. Pial vascular diameter and reactivity were measured in vivo through a cranial window and ex vivo in an organ chamber; cerebral microvascular endothelium was studied in culture for release of vasoactive mediators. Cerebral water content was recorded.
Results: Cold perfusion caused pial arteriole and venule constriction, whereas hypothermic circulatory arrest alone caused pial arteriole and venule dilatation. Cold perfusion caused a temporal loss of endothelium-dependent vasodilatation, most notably to bradykinin. Hypothermic circulatory arrest caused a loss of nitric oxide-mediated endothelium-dependent vasodilatation. Endothelium-independent vasoreactivity remained intact in both groups. Endothelial cells from the cold group had a vasoconstrictive secretory phenotype, whereas endothelial cells from the hypothermic circulatory arrest group had a vasodilatory phenotype. Cerebral water content was the same in both groups.
Conclusion: The increase in cerebrovascular resistance observed after cold cerebral perfusion is caused by resistance vessel constriction and may be promoted by an altered microcirculation. Hypothermic circulatory arrest alone is associated with endothelium-dependent vasoparesis. Both could contribute to cerebral injury in the early hours after operation.
| Introduction |
|---|
|
|
|---|
This study was designed to directly measure the effect of both continuous cold cerebral perfusion and HCA alone on cerebral water content, the cerebral resistance vessel diameter and reactivity, and the secretory phenotype of the cerebral microcirculation. It was hypothesized that continuous cold perfusion is associated with a cerebral vasoconstrictive phenotype when compared with HCA alone. To test this hypothesis, cerebral cortical water content, the in vivo response of pial arterioles and their in vitro reactivity in an organ chamber, and the secretory profile of the cerebral microvascular endothelium were measured during and after continuous cold perfusion and HCA.
| Materials and Methods |
|---|
|
|
|---|
The animals were placed in the prone position with their heads stabilized on a padded frame. A T-shaped scalp incision was performed to expose the skull for placement of a 10-mm closed cranial window for visualization of pial vessels.9
The window was placed over the left parietal cortex and equipped with 2 openings to serve as ports for infusion of vasoactive drugs and artificial cerebrospinal fluid (CSF; Na+ 150 mEq/L, K+ 3 mEq/L, Ca2+ 2.5 mEq/L, Mg2+ 1.2 mEq/L, Cl– 132 mEq/L, glucose 3.7 mmol/L, urea 6 mmol/L, and HCO3
– 25 mEq/L). The artificial CSF was equilibrated with gas containing 6.5% oxygen, 6.0% carbon dioxide, and 87.5% nitrogen at 37°C to give gas tensions and pH in the normal range for CSF.
Access for CPB was performed through a left thoracotomy. Heparin (300 U/kg) was administered, and the ascending aorta was cannulated with a 16F arterial cannula (CR Bard Inc, Haverhill, Mass). The right atrial appendage was cannulated with a 24F right-angle cannula (Edwards Lifescience LLC, Irvine, Calif). The CPB circuitry included a membrane oxygenator, a cardiotomy reservoir, and an arterial filter (Medtronic, Minneapolis, Minn). CPB flow was initiated at 100 mL/kg/min and adjusted to maintain MAP between 55 and 60 mm Hg. The alpha-stat pH management strategy was used. The degree of anticoagulation was monitored with activated clotting times.
In Vivo Diameter Studies
Two to four pial arterioles and venules (60–250 µm in diameter) were selected for observation over the left hemisphere at 40x magnification using an OpMi 1 stereomicroscope (Carl Zeiss, Oberkochen, West Germany). Vessel diameters were measured with an image-splitting eyepiece (Vicker's, AEI Imaging Splitting Eyepiece, Woburn, Mass). After recording baseline diameter measurements, 5 mL of 10–7 mol/L acetylcholine (Ach) solution (Sigma Chemical, St Louis, Mo) was infused under the window for assessment of endothelium-dependent vasodilatation. Ach acts on the endothelium via muscarinic receptor-mediated release of nitric oxide (NO).
Concentrations of 10–7 to 10–8 mol/L cause dilatation of pial arterioles to 110% to 120% of baseline.10
Higher concentrations of Ach act directly on the smooth muscle cell to cause contraction, overriding the endothelial cell mediated vasodilatory response. The direct smooth muscle effect can also occur when the receptor-mediated endothelial cell response is dysfunctional. After completion of diameter measurements, 5 mL of artificial CSF was infused to remove the Ach and allow vessels to return to their original diameters. Five milliliters of 10–7 mol/L sodium nitroprusside (Sigma Chemical, St Louis, Mo) was then infused to assess endothelium-independent vasodilatation, followed by washout with artificial CSF.
Experimental Protocol
After completion of the skull preparation, the animals were left undisturbed for 30 minutes before performing baseline measurements. Animals were then cooled for 30 minutes on CPB to 18°C and randomized to either COLD perfusion (n = 7), consisting of an additional 60 minutes of perfusion at 18°C, or 60 minutes of HCA (n = 4). All animals underwent aortic crossclamping and received 300 mL of cold crystalloid cardioplegia, followed by placement of an ice pack on the heart. After the period of cold perfusion or HCA, animals were rewarmed to 37°C over 60 minutes, separated from CPB, and allowed to perfuse normally for 60 minutes before sacrifice. Pial vessel measurements were taken at baseline, after 90 minutes of cold perfusion (COLD group only), after 60 minutes of rewarming, and 60 minutes after separation from CPB.
The animals were euthanized with a concentrated potassium solution under anesthesia, and brains were removed under sterile conditions. A portion of grey matter from the left hemisphere was placed in cold Hank's balanced salt solution (GIBCO, Grand Island, NY) for isolation of cerebral endothelial cells. A second piece of cortical grey matter was weighed, dried for 12 hours at 80°C, reweighed, and analyzed for cortical water content [(wet weight–dry weight/wet weight)] x 100. The remaining portion of the left hemisphere was placed in oxygenated cold physiologic saline solution (PSS; 4°C, 95% O2, 5% CO2) and transported to the laboratory for isolation of pial arterioles.
This study was approved by the Institutional Animal Care and Use Committee at the University of Vermont, and all animals were handled in a humane manner in compliance with the "Guide for the Care and Use of Laboratory Animal Resources" developed by the Institute of Laboratory Animal Resources.
In Vitro Diameter Studies
Pial resistance-size arteries (150–350 µm in diameter) were identified and removed from the left hemisphere under oxygenated cold PSS and cannulated on glass pipettes, mounted in a 5-mL myograph chamber (Living Systems Instruments, Burlington, Vt), and bathed in aerated PSS (20% O2, 5% CO2, 75% N2) at 37°C and pH 7.4. Diameters were measured with video edge detection equipment and recorded with data acquisition software (DI-700 with WinDaq waveform recording software, Dataq Instruments; Akron, Ohio). The vessels were pressurized to 20 mm Hg and allowed to equilibrate in a no-flow state using a burette manometer filled with PSS. Tissue viability was assessed by replacement of NaCl with 60 mmol/L KCL in PSS.
Vessels were discarded if the initial contraction was less than 40% of resting diameter, indicating nonviability. After washout with PSS and return to resting diameter, intravascular pressure was increased in stepwise fashion to assess for development of myogenic tone, which was defined as a percent decrease relative to the fully dilated diameter at a given intravascular pressure.11
Sequential application of increasing concentrations of Ach solution (10–9 to 10–5 mol/L in PSS) was performed. A period of 15 minutes was maintained between washouts to allow for equilibration. Vessel diameter was recorded before and after the addition of each solution, and percent change from baseline was recorded. Bradykinin solution (10–7 mol/L) was then applied for further assessment of endothelium-dependent vasodilatation. Sequential application of a series of increasing concentrations of the endothelium-independent vasodilator pinacidil (10–8 to 10–5 mol/L in PSS) was then applied and diameter measurements were recorded. Finally, diltiazem solution (5 x 10–5 mol/L in PSS, devoid of calcium) was added to establish the fully dilated diameter. Because of varying vessel sizes, diameter changes are expressed as percent change from baseline.
Cell Culture
Cortical gray matter was minced, placed in 0.01% type I collagenase (GIBCO) for 15 minutes, and followed by neutralization with (Dulbecco modified Eagle medium) DMEM (GIBCO) and filtration through mesh. An equal volume of DMEM was added, and the suspension was centrifuged at 1500g for 10 minutes. The pellet was resuspended in 15 mL of DMEM (supplemented with 20% fetal bovine serum, neomycin, and glutamine) and plated on 100 mm2 tissue culture dishes (Benton Dickinson, Lincoln Park, NJ). Dishes were placed in a humidified environment at 37°C with 5% CO2. The media was changed after 3 days and every 48 hours thereafter. The cells were passed at confluence and seeded in 25 cm2 tissue culture flasks (Benton Dickinson) and propagated in DMEM. Cells were characterized as endothelium by growth pattern, binding of Bandeiraea simplicifolia lectin (Sigma) and Factor VIII/vWF antibody (DAKO, Carpinteria, Calif), and by the absence of binding of glial fibrillatory acidic protein (Sigma).
Early passage (Passage 2) cells were studied in serum free media. Conditioned media was collected at 2, 16, and 24 hours and stored at –80°C, and subsequently assayed for prostacyclin (6-keto-PGF1
enzyme-linked immunosorbent assay, Caymen Chemical, Ann Arbor, Mich), endothelin (Immunometeric Assay System, Caymen), and NO (Nitrate/Nitrite Fluorometric Assay, Caymen). Results were standardized to cell count and total protein (BCA Protein Assay Reagent, Pierce, Rockford, Ill).
Statistical Analysis
Data are given as mean values ± 1 standard error of the mean. Differences between groups were tested using the unpaired Student t test. Differences within groups were tested using the paired Student t test.
| Results |
|---|
|
|
|---|
|
In Vivo Diameter Studies
Cold perfusion caused pial venule constriction that persisted after rewarming and restoration of normal perfusion. HCA was associated with venule dilatation after both rewarming and restoration of normal flow (Table 2
). Continuous cold perfusion was associated with pial arteriole constriction that persisted after rewarming and separation from CPB. In contrast, pial arteriole dilatation occurred with rewarming and reperfusion after HCA (Table 2).
|
In Vitro Diameter Studies
Pial arteries in both groups failed to develop myogenic tone in response to serial increases in intraluminal pressure. There was no difference between groups in response to the endothelium-independent vasodilator pinacidil. Vasodilatation in response to application of Ach was not seen in either group. Instead, vasoconstriction occurred in the HCA group at lower concentrations of Ach, indicating endothelial cell dysfunction and unopposed smooth muscle cell activation (Table 3
).
|
Cell Culture
Microvascular cerebral endothelial cells isolated from animals exposed to continuous cold perfusion secreted more endothelin and less prostacyclin than animals undergoing HCA. NO was not detected in either group (Table 4
).
|
| Discussion |
|---|
|
|
|---|
Continuous cold perfusion caused pial arteriole and venule constriction. Endothelial-mediated arteriole dilatation was impaired during cold perfusion and rewarming but recovered after a period of normal pulsatile perfusion. Others have noted a loss of endothelial-mediated cerebral vasodilatation during cold perfusion on CPB.12
Cerebral arterioles isolated from the cold perfusion animals failed to undergo NO-mediated vasodilatation, implying persistent endothelial cell dysfunction. This was confirmed by a vasoconstrictive response to bradykinin. Bradykinin normally induces vasodilatation in cerebral arterioles by activating endothelial B2 receptors. Bradykinin can produce vasoconstriction by stimulating B1 receptors on smooth muscle cells in the presence of dysfunctional or absent endothelium. Bradykinin is also known to cause vasoconstriction in the presence of inducible NO synthase in certain pathologic states.13
Future studies could address the cold perfusion-induction of cerebral inducible NO synthase or the induction of cerebrovascular bradykinin receptor re-distribution.
Endothelial cells isolated from the microcirculation of the COLD group showed a constrictive secretory profile. Endothelin secretion was greater in the COLD group when compared with the HCA group. Endothelin is a potent endothelial cell-derived cerebral vasoconstrictor. Pial arteriole endothelial cells have a heightened responsiveness to endothelin relative to systemic arterioles.14
Exposure of pial arterioles to endothelin increases their contractile response to hemolyzed blood products,15
such as those released during CPB. Substances generated during CPB also induce the synthesis of endothelin, and include thrombin, transforming growth factor-ß, angiotensin II, and arginine vasopressin.16
HCA alone is known to induce endothelin-1 mRNA expression in pulmonary arteries and is associated with an increase in the pulmonary vascular resistance.17
HCA was not associated with cerebral vasoconstriction. Pial arterioles dilated after rewarming from HCA and returned to near baseline diameter after 60 minutes of normal pulsatile perfusion. There was, however, a loss of endothelial-mediated vasodilatation in vessels after rewarming, which did not completely normalize after restoration of normal perfusion. Arterioles isolated from HCA animals constricted with application of Ach at doses that normally produce vasodilatation, a finding also noted in the rewarming phase in vivo after HCA. These findings indicate direct unopposed action of Ach on the smooth muscle cell secondary to NO-related endothelial cell dysfunction and are seen in other organ systems after both HCA and hypothermic CPB.18,19
This may be related, at least partially, to abnormal endothelial cell-neutrophil interaction20
or endothelial cell-platelet interaction.21
HCA was associated with a vasodilatory phenotype in cultured microvascular endothelial cells, as evidenced by up-regulation of prostacyclin secretion. Prostacyclin, a potent vasodilator, is released from cerebral endothelial cells and into the CSF during brain ischemia.22,23
Prostacyclin release may serve to enhance cerebral blood flow to meet metabolic demand and may, therefore, contribute to the vasodilatation seen in arterioles and venules during rewarming from HCA alone. Similar findings have been noted after resuscitation from hemorrhagic shock.23
Vasodilatation after rewarming from HCA could also represent a maladaptive response known as luxury perfusion, a risk factor for embolic stroke as speculated by some authors.5
NO was not detected in conditioned media from cerebral endothelial cells in either group, and, as noted, NO-mediated vasodilatation was absent in isolated cerebral arterioles. Others have noted a cerebrovascular NO deficit after HCA,24
and NO production by cerebral endothelial cells is impaired after hemorrhage-induced cerebral ischemia.23
The direct smooth muscle response to vasodilators remained intact in this study. However, there was a loss of myogenic tone to stepwise application of intraluminal pressure in isolated arteries from both groups. This could signify a loss of pressure autoregulation or a loss of spontaneous vasomotion in cerebral arterioles, which could contribute to abnormalities in local cerebral oxygen delivery. Loss of pressure autoregulation and dysfunctional endothelial cell-mediated vasodilatory mechanisms may contribute to low flow states after HCA7
and could predispose patients to neurologic injury in the early hours after operation when hemodynamic instability commonly occurs.
Despite the theoretic clinical advantage of antegrade cerebral perfusion over HCA alone, or retrograde cerebral perfusion, findings of the current study suggest that cold cerebral perfusion may cause intrinsic abnormalities in the cerebral vasculature that could lead to low flow states early after operation. In at least 1 clinical study antegrade cerebral perfusion was associated with worse neurocognitive impairment when compared with HCA alone.25
Others have shown that antegrade perfusion at lower flow rates using mild to moderate hypothermia improves clinical outcome.3,6,26-28
Lower flow rates and higher temperatures may limit the vasoconstrictive response and endothelial cell dysfunction seen with high flow rates and profound hypothermia, while still providing nutritive blood flow.
Limitations
Nonselective antegrade cerebral perfusion was used in this study. The cerebral flow rate is unknown. Higher flows are known to induce vasoconstriction.29
Much lower flow rates, however, have also been shown to increase cerebral vascular resistance.7
Extrapolating from the adult human, in whom 40% to 45% of systemic flow is delivered to the upper body during CPB, it is conceivable that our model delivered upper body flow in the range of 18 to 35 mL/kg/min (mean 26–29 mL/kg/min) based on our experimental systemic flow rate during cold perfusion. In a recent porcine study,30
MAP-dependent flow delivered into the isolated aortic arch was 16 mL/kg/min at a MAP of 50 mm Hg and 34 mL/kg/min at a MAP of 70 mm Hg. It is reasonable to presume that nonselective flow through the common brachiocephalic trunk in our study (mean MAP 56 mm Hg during COLD perfusion) was in the lower range of these flows, making them clinically relevant.
Prolonged cooling before circulatory arrest and antegrade perfusion is often performed to obtain isoelectric electroencephalogram in anticipation of long arrest times. Systemic cooling times are often in excess of 50 minutes, at perfusate temperatures of 15°C to 18°C. The systemic cooling time in this study of 30 minutes, followed by 60 minutes of continuous flow, will fall into perfusion ranges used clinically, most commonly during total arch replacement. These data, however, may not have relevance to shorter periods of cold perfusion, such as used in hemiarch replacement. Finally, it would be unwise to extrapolate these data to pediatric patients, because both mature animals and the
-stat pH management strategy were used in this study.
| Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. O. Algra, V. N. N. Kornmann, I. van der Tweel, A. N. J. Schouten, N. J. G. Jansen, and F. Haas Increasing duration of circulatory arrest, but not antegrade cerebral perfusion, prolongs postoperative recovery after neonatal cardiac surgery J. Thorac. Cardiovasc. Surg., February 1, 2012; 143(2): 375 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Jonsson, A. Morell, V. Zemgulis, E. Lundstrom, T. Tovedal, G. M. Einarsson, S. Thelin, H. Ahlstrom, A. Bjornerud, and F. Lennmyr Minimal Safe Arterial Blood Flow During Selective Antegrade Cerebral Perfusion at 20{degrees} Centigrade Ann. Thorac. Surg., April 1, 2011; 91(4): 1198 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Brady, J. O. Mytar, J. K. Lee, D. E. Cameron, L. A. Vricella, W. R. Thompson, C. W. Hogue, and R. B. Easley Monitoring Cerebral Blood Flow Pressure Autoregulation in Pediatric Patients During Cardiac Surgery Stroke, September 1, 2010; 41(9): 1957 - 1962. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |